Feb 16, 2017 by Brian FeroldiWhy ConforMIS Stock Is Tanking TodayShares plunged after the company announced disappointing guidance for 2017.
Feb 16, 2017 by Brian FeroldiAlkermes' Revenue Soars, Projects an Exciting Year AheadThe biopharma posted strong quarterly revenue growth and provided investors with reasons to remain optimistic about 2017.
Feb 15, 2017 by Brian FeroldiHere's How to Find the Best Dividend StocksPut your dividend-paying stocks to the test by looking at these three key metrics.
Feb 15, 2017 by Brian Feroldi, Dan Caplinger, Travis Hoium, and Matt DiLallo4 High-Yield Dividend Stocks You Don't Have to BabysitLooking for a top-notch income stock to buy and hold? Our team of Fools thinks you should give these four companies a closer look.
Feb 15, 2017 by Brian Feroldi, Dan Caplinger, Travis Hoium, and Matt DiLallo4 Stocks to Buy Near 52-Week LowsInterested in finding a bargain in today's overheated market? Consider giving these four cheap stocks a closer look.
Feb 14, 2017 by Brian FeroldiHere's Why Cynosure, Inc. is Soaring TodayShares skyrocket after the company accepts a buyout offer from Hologic.
Feb 13, 2017 by Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan WathenBillionaires Are Dumping These 5 Stocks. Should You?Hedge-fund managers have recently said goodbye to these five stocks. Should you follow suit?
Feb 13, 2017 by Brian FeroldiWhy Sage Therapeutics Jumped TodayShares rocket higher in response to encouraging top-line results from a Phase 2 clinical trial.
Feb 10, 2017 by Brian FeroldiInfinera's Sales Fall, but the Bottom Might Be in SightInfinera reported falling sales and a quarterly loss, but offered investors hope that the worst of the declines might finally be over.
Feb 10, 2017 by Brian FeroldiHere's Why Infinera Is SoaringShares skyrocket on better-than-anticipated fourth-quarter results and revenue guidance that topped expectations.
Feb 9, 2017 by Brian FeroldiFormFactor, Inc. Delivers on Its PromisesThe semiconductor probe card manufacturer reported strong revenue and adjusted profit growth.
Feb 9, 2017 by Brian FeroldiWhy Paycom Software, Inc Stock Is Soaring TodayAn upbeat fourth-quarter earnings report that featured bullish guidance puts traders in a good mood.
Feb 9, 2017 by Brian FeroldiPaycom Software, Inc Tops Its Guidance and Issues a Bullish OutlookThe HR software provider meaningfully expanded its top and bottom lines and projected that the good times will continue.
Feb 9, 2017 by Brian Feroldi3 Top Stocks for Low-Risk InvestorsInterested in putting money to work in the stock market without taking on a lot of risk? Here's why I think you should consider buying Johnson & Johnson, American Water Works, and Church & Dwight.
Feb 8, 2017 by Brian FeroldiWhy Coherus Biosciences Is Falling TodayShares drop after management announces the pricing terms of a recently announced secondary offering.
Feb 8, 2017 by Brian FeroldiGilead Sciences Just Lost $9 Billion in Market Value -- Here's WhyFalling sales mixed with disappointing guidance sends shares in a tailspin.
Feb 7, 2017 by Brian FeroldiWhy Teva Pharmaceuticals Industries Just Lost $1.5 Billion In Market ValueThe surprise removal of its CEO causes shares to tumble.
Feb 7, 2017 by Brian Feroldi3 Reasons CVS Health Corporation Stock Could FallThe retail pharmacy giant may have a few tailwinds at its back, but its stock is far from risk-free.
Feb 6, 2017 by Brian Feroldi, Jason Hall, and Jamal Carnette, CFA3 Stocks We're Never SellingOur team of Fools can't ever see themselves ever parting ways with these three businesses.
Feb 6, 2017 by Brian FeroldiWhy Rite Aid Plunged 31.3% in JanuaryTraders headed for the exits over concerns that the company's deal with Walgreens Boots Alliance might not go through.
